Molecular and immunomodulatory actions of new antiasthmatic agents: exploring the diversity of biologics in Th2 endotype asthma
Asthma is a major respiratory disorder characterised by chronic inflammation and airway remodelling. It affects about 1–8% of the global population and is responsible for over 461,000 deaths annually. Until recently, the pharmacotherapy of severe asthma involved high doses of inhaled corticosteroids...
Main Authors: | Okwuofu, Emmanuel Oshiogwe, Chee, Audrey Hui Yong, Chee, Jonathan Woei Lim, Stanslas, Johnson |
---|---|
Format: | Article |
Published: |
Academic Press
2022
|
Similar Items
-
Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma
by: Emmanuel Oshiogwe Okwuofu, et al.
Published: (2022-07-01) -
An Andrographis paniculata Burm. Nees extract standardized for three main Andrographolides prevents house dust mite-induced airway inflammation, remodeling, and hyperreactivity by regulating Th1/Th2 gene expression in mice
by: Sulaiman, Ibrahim, et al.
Published: (2024) -
Novel Biological Therapies for Severe Asthma Endotypes
by: Corrado Pelaia, et al.
Published: (2022-05-01) -
Asthma: endotypes and phenotypes at a pediatric age
by: Francisco Muñoz-López
Published: (2019-06-01) -
Discerning asthma endotypes through comorbidity mapping
by: Gengjie Jia, et al.
Published: (2022-11-01)